GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Verici Dx PLC (OTCPK:VRCDF) » Definitions » Days Inventory

Verici Dx (Verici Dx) Days Inventory : 0.00 (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Verici Dx Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Verici Dx's Average Total Inventories for the six months ended in Jun. 2023 was $0.00 Mil. Verici Dx's Cost of Goods Sold for the six months ended in Jun. 2023 was $0.00 Mil. Hence, Verici Dx's Days Inventory for the six months ended in Jun. 2023 was 0.00.

The historical rank and industry rank for Verici Dx's Days Inventory or its related term are showing as below:

VRCDF's Days Inventory is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 65.4
* Ranked among companies with meaningful Days Inventory only.

Verici Dx's Days Inventory stayed the same from Jun. 2022 (0.00) to Jun. 2023 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Verici Dx's Inventory-to-Revenue for the six months ended in Jun. 2023 was 0.00.


Verici Dx Days Inventory Historical Data

The historical data trend for Verici Dx's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verici Dx Days Inventory Chart

Verici Dx Annual Data
Trend Dec20 Dec21 Dec22
Days Inventory
- - -

Verici Dx Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23
Days Inventory - - - - -

Competitive Comparison of Verici Dx's Days Inventory

For the Diagnostics & Research subindustry, Verici Dx's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Verici Dx's Days Inventory Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Verici Dx's Days Inventory distribution charts can be found below:

* The bar in red indicates where Verici Dx's Days Inventory falls into.



Verici Dx Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Verici Dx's Days Inventory for the fiscal year that ended in Dec. 2022 is calculated as

Days Inventory (A: Dec. 2022 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2021 ) + Total Inventories (A: Dec. 2022 )) / count ) / Cost of Goods Sold (A: Dec. 2022 )*Days in Period
=( (0 + 0) / 1 ) / 0*365
=0 / 0*365
=N/A

Verici Dx's Days Inventory for the quarter that ended in Jun. 2023 is calculated as:

Days Inventory (Q: Jun. 2023 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Dec. 2022 ) + Total Inventories (Q: Jun. 2023 )) / count ) / Cost of Goods Sold (Q: Jun. 2023 )*Days in Period
=( (0 + 0) / 1 ) / 0.003*365 / 2
=0 / 0.003*365 / 2
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Verici Dx  (OTCPK:VRCDF) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Verici Dx's Inventory Turnover for the six months ended in Jun. 2023 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Verici Dx's Inventory to Revenue for the six months ended in Jun. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Verici Dx Days Inventory Related Terms

Thank you for viewing the detailed overview of Verici Dx's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Verici Dx (Verici Dx) Business Description

Traded in Other Exchanges
Address
19 Stanwell Road, Avon House, Penarth, Cardiff, GBR, CF64 2EZ
Verici Dx PLC is an immuno-diagnostics development company. The company is focused on developing diagnostics technologies which will help understand the outcomes of an organ transplant surgery. There are two products for clinical validation and commercialization: Clarava, which is a pre-transplant prognosis for the risk of early acute rejection; and Tuteva, a post-transplant diagnostic focused upon acute cellular rejection including sub-clinical rejection not being diagnosed through the current standard of care of rising serum creatine levels. The business of the Group comprises a single activity, that of the development of prognostic and diagnostic tests for kidney transplant patients.

Verici Dx (Verici Dx) Headlines

No Headlines